www.fdanews.com/articles/88426-inyx-s-ashton-pharmaceuticals-selected-to-produce-generic-drugs-for-european-markets
INYX'S ASHTON PHARMACEUTICALS SELECTED TO PRODUCE GENERIC DRUGS FOR EUROPEAN MARKETS
July 17, 2006
Inyx, Inc., a specialty pharmaceutical company focused on niche drug delivery technologies and products, announced today that its wholly owned U.K. subsidiary, Ashton Pharmaceuticals Ltd., has been selected by a leading Indian specialty pharmaceutical company to manufacture a range of generic drugs for the United Kingdom and other European countries.
Yahoo
Finance